NF-κB as a Therapeutic Target in Multiple Myeloma-Reference-Cited by-同舟云学术

NF-κB as a Therapeutic Target in Multiple Myeloma

Published:2002-05 Issue:19 Volume:277 Page:16639-16647
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Hideshima Teru,Chauhan Dharminder,Richardson Paul,Mitsiades Constantine,Mitsiades Nicholas,Hayashi Toshiaki,Munshi Nikhil,Dang Lenny,Castro Alfredo,Palombella Vito,Adams Julian,Anderson Kenneth C.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference45 articles.

1. THE NF-κB AND IκB PROTEINS: New Discoveries and Insights

2. The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors.

3. Bridging the Gap: Composition, Regulation, and Physiological Function of the IκB Kinase Complex

4. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB

5. NF-κB Regulates Transcription of the Mouse Telomerase Catalytic Subunit

Cited by 817 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inducible gene expression of IκB-kinase ε is dependent on nuclear factor-κB in human pulmonary epithelial cells;Biochemical Journal;2024-07-12

2. Discovering Potential in Non-Cancer Medications: A Promising Breakthrough for Multiple Myeloma Patients;Cancers;2024-06-28

3. Topical JAK inhibition ameliorates EGFR inhibitor–induced rash in rodents and humans;Science Translational Medicine;2024-06-19

4. Combination of bortezomib and venetoclax targets the pro-survival function of LMP-1 and EBNA-3C of Epstein-Barr virus in post-transplant lymphoproliferative disorder;2024-05-13

5. The ERK1/2-Elk1, JNK-cJun, and JAK-STAT Transcriptional Axes as Potential Bortezomib Resistance Mediators in Prostate Cancer;2024-04-20